Product Type Segment Analysis: Surgical Instruments (Largest Segment) vs Surgical Navigation Systems (Fastest-Growing Segment)

Surgical instruments accounted for the largest share of 45.58% in 2026 in the sinus tissue resection devices market. Their leading position is supported by their essential role across a wide range of sinus procedures, including tissue removal, dissection, cutting, and other operative interventions. Surgical instruments are routinely required in both conventional and endoscopic procedures, making them a fundamental component of sinus surgery. Their broad clinical applicability, established use among surgeons, and continued demand for reliable tools that support precise tissue management have strengthened the segment's position.

Surgical navigation systems are expected to be the fastest-growing product type, driven by the increasing emphasis on precision, anatomical visualization, and procedural safety in complex sinus surgeries. These systems provide surgeons with enhanced spatial guidance during procedures, particularly when operating near delicate anatomical structures. Growing adoption of technology-assisted surgical workflows and increasing demand for more accurate, minimally invasive interventions are supporting the integration of navigation systems into advanced sinus tissue resection procedures.

Procedure Segment Analysis: Functional Endoscopic Sinus Surgery (FESS) (Largest Segment) vs Balloon Sinuplasty (Fastest-Growing Segment)

Functional endoscopic sinus surgery (FESS) dominated the sinus tissue resection devices market and held the largest share of 53.64% in 2026. Its widespread adoption is attributed to its established role in treating persistent sinus disease through minimally invasive endoscopic techniques. FESS enables surgeons to improve sinus drainage and remove obstructive or diseased tissue while providing direct visualization of the surgical area. The procedure's broad applicability in the management of chronic sinus conditions and its established clinical acceptance continue to support demand for associated tissue resection devices.

Balloon sinuplasty is anticipated to be the fastest-growing procedure segment, supported by rising interest in less invasive approaches for managing appropriate sinus conditions. The procedure can help improve sinus passageways while reducing the extent of tissue disruption associated with more invasive surgical interventions. Increasing patient preference for minimally invasive treatment options, together with ongoing improvements in procedural techniques and device-assisted sinus care, is encouraging broader adoption of balloon-based interventions.

Application Segment Analysis: Chronic Sinusitis (Largest Segment) vs Benign Sinus Tumors (Fastest-Growing Segment)

The chronic sinusitis application segment led the sinus tissue resection devices market, accounting for the largest share of 47.7% in 2026. Persistent or recurrent sinus inflammation can require procedural intervention when medical management does not provide sufficient relief, creating sustained demand for tissue resection devices. The need to address obstructed sinus pathways, diseased tissue, and recurring symptoms supports the use of surgical instruments and endoscopic technologies in this application. Continued demand for effective management of long-term sinus conditions has therefore reinforced chronic sinusitis as the leading application.

Benign sinus tumors are expected to be the fastest-growing application segment, supported by the increasing use of advanced surgical techniques for the precise removal of abnormal tissue. Treatment of these tumors often requires careful visualization and controlled tissue resection, creating demand for specialized instruments and technology-assisted procedures. Greater emphasis on accurate diagnosis, minimally invasive tumor management, and improved surgical precision is contributing to the expanding adoption of sinus tissue resection devices in this application.